[68Ga]Ga-FAPI-46 PET用于无创检测肺纤维化疾病活动度
在博来霉素诱导的小鼠肺纤维化模型中,CT仅在造模后14天检出纤维化反应差异,而[68Ga]Ga-FAPI-46 PET在7天和14天均显示博来霉素组肺摄取显著高于对照组,且14天(1.01±0.12%IA/cc)较7天(0.33±0.09%IA/cc)显著升高(P=0.0012)。FAPI PET可检测肺纤维化的存在与活动度,作者认为其有望用于评估早期疾病活动度和治疗效果。
要点
- CT仅在小鼠造模后14天检出纤维化反应差异。
- 博来霉素组[68Ga]Ga-FAPI-46肺摄取在7天和14天均显著高于对照组。
- 14天肺摄取1.01±0.12%IA/cc较7天0.33±0.09%IA/cc显著升高(P=0.0012)。
核心结论
- CT无法评估小鼠IPF模型的疾病活动度,而FAPI PET可检测肺纤维化的存在与活动度,作者认为其有望用于评估肺纤维化患者的早期疾病活动度和治疗效果。
研究设计与样本
- 小鼠肺纤维化模型研究:博来霉素(1 U/kg)气管内给药诱导肺纤维化,对照组气管内给予生理盐水,各组亚组(n=3-5)于造模后7天和14天静脉注射[68Ga]Ga-FAPI-46后行1小时动态PET/CT。
- 成像后处死动物行离体伽马计数与组织学对照。
主要发现
- CT仅在博来霉素给药后14天检出纤维化反应差异。
- 博来霉素组[68Ga]Ga-FAPI-46肺摄取在7天和14天均显著高于对照组。
- 注射后60分钟,博来霉素组14天肺摄取(1.01±0.12%IA/cc)较7天(0.33±0.09%IA/cc)显著升高(P=0.0012)。
- 上述结果与组织学所见纤维化生成和FAP表达增加一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The lack of effective molecular biomarkers to monitor idiopathic pulmonary fibrosis (IPF) activity or treatment response remains an unmet clinical need. Herein, we determined the utility of fibroblast activation protein inhibitor for positron emission tomography (FAPI PET) imaging in a mouse model of pulmonary fibrosis. METHODS: Pulmonary fibrosis was induced by intratracheal administration of bleomycin (1 U/kg) while intratracheal saline was administered to control mice. Subgroups from each cohort (n = 3-5) underwent dynamic 1 h PET/CT after intravenously injecting FAPI-46 radiolabeled with gallium-68 ([68 Ga]Ga-FAPI-46) at 7 days and 14 days following disease induction. Animals were sacrificed following imaging for ex vivo gamma counting and histologic correlation. [68 Ga]Ga-FAPI-46 uptake was quantified and reported as percent injected activity per cc (%IA/cc) or percent injected activity (%IA). Lung CT density in Hounsfield units (HU) was also correlated with histologic examinations of lung fibrosis. RESULTS: CT only detected differences in the fibrotic response at 14 days post-bleomycin administration. [68 Ga]Ga-FAPI-46 lung uptake was significantly higher in the bleomycin group than in control subjects at 7 days and 14 days. Significantly (P = 0.0012) increased [68 Ga]Ga-FAPI-46 lung uptake in the bleomycin groups at 14 days (1.01 ± 0.12%IA/cc) vs. 7 days (0.33 ± 0.09%IA/cc) at 60 min post-injection of the tracer was observed. These findings were consistent with an increase in both fibrinogenesis and FAP expression as seen in histology. CONCLUSION: CT was unable to assess disease activity in a murine model of IPF. Conversely, FAPI PET detected both the presence and activity of lung fibrogenesis, making it a promising tool for assessing early disease activity and evaluating the efficacy of therapeutic interventions in lung fibrosis patients.
引用
- Rosenkrans ZT, Massey CF, Bernau K, et al. [68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity. Eur J Nucl Med Mol Imaging. 2022. PMID: 35556159. doi:10.1007/s00259-022-05814-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。